It is interesting that two of the newest members of the B.O.D. are Atlanta area based. I do not know this for sure, but I think it is reasonable to infer that CYDY has a strong shareholder base in Georgia. As one of those Georgia shareholders, I welcome Dr. Kelly's Chairmanship, both from a business perspective, as well as from a medical one. IMO, the BOD is probably awash in consultants, shareholders, and bankers offering business advice, so I'm confident they've got the business component covered. As a long time shareholder, I'd like to see a SP which better represents the value I see in CYDY. That said, low prices have provided a wonderful entry point for new SHs and for existing SHs to add shares, as well.
In some ways, CYDY's value has tracked more like a limited liquidity "private equity investment" than a publicly traded company, which is most likely related to it not being on a major exchange and how it has had to raise capital. It has certainly not been an investment for the feint of heart.
News 
Market Data 
Discover 
